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Over the past two years, agricultural biotechnology has captured public
attention in the United States, notably with news stories on the monarch
butterfly studies and StarLink™ corn. In addition, interest groups have been
engaged in an intensive struggle for consumers’ hearts and minds. Opponents
of biotechnology, such as Greenpeace and the organic-farming industry, have
used a variety of tactics to frighten consumers about potential risks. On the
other side, the biotechnology industry, through the Council for Biotechnology
Information, has launched an intensive public-information campaign stressing
potential benefits. Therefore, it is helpful at this stage to evaluate available
survey research concerning American consumers’ awareness and acceptance
of agricultural biotechnology and foods with genetically modified (GM)
ingredients.
Before beginning this assessment, it will be useful to put agricultural
biotechnology into the larger context of innovation diffusion, which has been
the subject of over 50 years of research (Rogers, 1995). The basic conclusion
from that work was that anything new takes time to garner awareness and gain
acceptance and adoption. Early studies of hybrid corn conducted in central
Iowa during the 1930s found that over a decade passed before farmers in
general were using the higher-yielding varieties. Some farmers objected to
the fact that they could no longer save their seed for planting—similar to
technology fees and crop-protection technology (i.e. the “terminator” gene)
associated with modern plant biotechnology.
Consumer adoption of new food technologies also takes time. The microwave
oven is an interesting example. When introduced, there were concerns over
risks of radiation leakage into the kitchen. Over time, as consumers recognized
the benefits and when concerns over risks were addressed, most people
accepted microwave ovens in their homes. It is interesting that adoption of a
new technology varies between cultures. French consumers are much less
accepting of foods prepared by microwave than are Americans. Also, the French
are appalled by another American innovation: the drive-through restaurant.
Another example of societal resistance to new technology is pasteurization, as
described by Joseph Hotchkiss in this volume.
Given the fact that no new technology will ever be 100% accepted by the
public, it is important to examine some unique characteristics of the biotech-
nology controversy that make associated innovations more likely to meet with
consumer resistance. First, agricultural biotechnology is a relatively complex
subject. Full understanding of the technical issues associated with benefits and
risks requires at least some knowledge of agriculture, food processing, and of
the biological sciences. Not many consumers in the United States or elsewhere
have direct connection with agriculture and food processing. Most take it for
granted that food will be readily available and do not think, or care, much
about how it gets to the store or restaurant. In addition, most people are
unfamiliar with the advances in the biological sciences that have occurred over
the past two decades. This lack of literacy makes some consumers apprehensive
about developments in food biotechnology.
It is also important to consider how consumers receive information about
food biotechnology, and the messages that they are hearing. Most of what
consumers learn about any innovation comes through the filter of the mass
media, which have a tendency to feature sensational news stories. Also, the
media oversimplify issues to fit within their sound-bite framework. Stories
about agricultural biotechnology tend to have a tone of conflict and controversy
that makes people concerned. Once something is in the media it becomes part
of the public agenda. Up to that point, most people have little awareness of, or
interest in, a particular subject. Clearly, media coverage of biotechnology in the
United States has increased over the past few years.
Another major factor that is slowing consumer acceptance of biotechnology
involves the aggressive campaigns of a variety of special interest groups (Hoban,
1995). Groups such as Greenpeace and the Earth Liberation Front are trying to
shake public confidence in science and the federal regulatory process. They do
not find it necessary to prove their assertions, but are satisfied to raise doubts
and fear. They also capture media attention with extreme tactics, such as
destroying research plots, harassing food companies, and engaging in street
theater. These groups have a variety of motives for their campaigns, including
anti-corporate and anti-globalization ideologies. They have a vested interest in
building the controversy since it increases their donations and membership. In
addition, the organic food industry supports the anti-biotechnology movement
because some consumers are motivated to spend more money on organic foods.
Another problem for agricultural biotechnology is that benefits to consumers
from the early products were not obvious. Many observers note that agricul-
tural biotechnology tends to be less acceptable to consumers than is medical
biotechnology. This makes sense given the fact that sick people are likely to
accept risk from a medical treatment in order to regain health. Patients are
likely to trust their doctors and follow their advice without question. The
situation is quite different with food. People feel qualified to make their own
decisions and are more risk-adverse, especially when they see few direct
benefits from a new food-production technology.
For the most part, new medicines developed through biotechnology have
been well accepted by consumers. However, developments in human genetics
and genomics may prove to be even more controversial than food biotechnol-
ogy. For example, media coverage of human cloning and stem-cell research has
captured public attention recently, tending to push agricultural biotechnology
into the background. Society has some important and real concerns to deal
with. Policy makers and scientists are only now beginning to grapple with
questions about genetic privacy, genetic discrimination, and eugenics. Given
that the public and the media have a limited attention span, it is possible that
agricultural biotechnology may well be viewed as more acceptable by
comparison.
With this background in mind, I now turn to an assessment of recent
research on consumer awareness and attitudes about agricultural biotechnology.
In general, the studies that I will review involved telephone surveys of the
Americans. Most involved approximately 1,000 interviews, representing a
confidence level of just over 3%. Where possible, I will highlight trends in the
results over time.
CONSUMER AWARENESS OF BIOTECHNOLOGY
The process of innovation adoption starts with awareness. For almost a decade,
consumers have been asked in various surveys, “How much have you heard or
read about biotechnology—a lot, some, a little, or nothing?” (Hoban, 1996,
2001; IFIC, 2001.) It is reasonable to equate awareness with having heard
something or a lot (Figure 1). There are several notable trends in consumer
awareness of biotechnology in the United States. For the first half of the 1990s,
it remained rather low at about one-third. It hit a peak in 1997 when a survey
was conducted soon after the news about Dolly, the cloned sheep. Then
awareness dropped until May 2000, but has grown gradually since, to 53% in
June 2001.
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Most Americans are not aware of the extent to which biotechnology
has become part of their food supply. According to a January 2001 survey
conducted by the Pew Foundation for Agricultural Biotechnology, few
consumers believed that GM foods are in wide use in the food supply, and
even fewer believed that they have eaten them (Pew, 2001). Most consumers,
60%, believed that less than half of the food in grocery stores contains GM
ingredients, while 38% thought that less than a quarter of food contains such
ingredients. Only 14% of consumers believed that more than half of our food
contains GM ingredients, which was the correct answer. Additionally, few
Americans recognized that they had already eaten GM foods. Only 19% said
they had eaten GM foods, 62% said they had not, and 19% said they did not
know.
At the same time, consumers were uncertain about how safe GM foods are.
When asked initially, with little background information, whether GM foods
are safe, almost half said that they did not know, 29% said they are basically
safe, and 25% said they are basically unsafe. However, after being informed that
more than half of the products at the grocery store contain GM ingredients,
almost half said that GM foods are safe, only 21% said that they are unsafe, and
31% said they were unsure (Figure 2). In fact, one in five of those who initially
said GM foods were unsafe, changed their minds. Thus, when some consumers
learn how widespread are GM foods, they are more likely to believe they are
safe. However, it is also true that some consumers become angry when they
realize that they have not been told about the widespread presence of GM
ingredients.
Figure 1. American consumers’ awareness of biotechnology, 1992–2001
(Hoban, 1996, 2001; IFIC, 2001).
. . . few Americans recognized that they had
already eaten GM foods.
CONSUMER ACCEPTANCE OF BIOTECHNOLOGY
Consumer acceptance has been measured in a variety of ways in different
surveys. I have had the opportunity to repeat the same set of questions with
three surveys through my own research (Hoban and Kendall, 1994), as well as
in a survey conducted by Angus Reid, Inc. in 2000 (personal communication).
The objective was to assess the level of consumer acceptance of three
applications of biotechnology (Figure 3). In the case of insect-protected crops,
acceptance was higher in 1992 (63%) and 1994 (67%) than in 2000 (51%).
The same overall trend was noted for disease resistance in farm animals and for
larger, faster-growing fish; but these applications were relatively less acceptable
than plants at all points in time. This is of particular concern, because disease-
resistant animals and faster-growing fish are either on the market or close to
commercialization.
Figure 2. American consumers’ views on the safety of genetically
modified foods (Pew, 2001).
Figure 3. American consumers’ acceptance of three applications of
biotechnology (Hoban and Kendal, 1994; Angus Reid, Inc., pers. comm.).
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Surveys conducted by Hoban and Miller (1998) and by Priest (2000)
evaluated more-recent trends in American consumers’ support for four
applications of biotechnology (Figure 4). Compared to 1998, a greater
percentage of consumers in 2000 believed that applications of biotechnology
to crops and foods should be encouraged. It is interesting to note that
consumers tended to view insect-protected crops as more acceptable than
improved foods. Support for development of new human genetic screening
techniques rose significantly between 1998 and 2000 (Figure 4). At the same
time, concerns have been raised in the media about loss of genetic privacy
and the potential for discrimination that could result from increased access
to such genetic information.
It is instructive to compare these results from the United States with
trends for the same questions asked on the Eurobarometer2 in 1996 and 1999
(Figure 5). In Europe, public support for all four applications of biotechnology
dropped significantly during this period, which corresponds to the growth
of the public controversy. It is understandable that agricultural and food
applications would become less acceptable given the fact that they were the
focus of opponents’ campaigns. However, it is noteworthy that support for the
two medical applications of biotechnology also dropped significantly. Such a
pattern could mean some difficult challenges for the European economy and
diminished prospects for new advances in health care.
Figure 4. American consumers’ support for four applications of
biotechnology (Hoban and Miller, 1998; Priest, 2000).
2European Commission public-opinion surveys, http://europa.eu.int/comm/dg10/epo/.
IMPACTS OF THE STARLINK™ CORN CONTROVERSY
One incident that captured the attention of the media in the United States
involved the discovery in food of a protein from a corn variety that had not
been approved for human consumption, i.e., StarLink™. To evaluate consumer
response to the story, I conducted a survey for the Grocery Manufacturers
of America in October 2000, immediately after the taco-shell recall was
announced. Most of the questions were asked again in January 2001 by the
International Food Information Council (IFIC, 2001). These results indicate
no significant impact from the StarLink™ controversy on consumers’ attitudes
or behavior.
Early in the interview, before any mention of StarLink™ or biotechnology,
respondents were asked the open-ended question, “Over the past few months,
what, if anything, have you been avoiding or eating less of?” (Figure 6). The
largest percentage indicated that they had not changed their eating habits in
any way. This was particularly true in January, which may reflect holiday eating
patterns. Of those who had limited their consumption of a particular food,
responses were almost evenly divided among fats, carbohydrates, or meat and
dairy products. No one in either survey said they had stopped eating taco shells
or corn, nor was there any other reference to biotechnology. The next open-
ended question was, “What if anything are you most concerned about when
it comes to food safety?” The most common responses involved microbial
contamination or pesticides. Only 2 to 3% mentioned anything related to
biotechnology or genetic modification.
Figure 5. European consumers’ support for four applications of
biotechnology, 1996 and 1999 (Eurobarometer).
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The interview later posed specific questions about biotechnology and the
StarLink™ issue. One question that I developed in 1995 has been repeated
in other surveys (FMI, 1997; IFIC, 2001) to indicate the extent to which
consumers are willing to buy tomatoes or potatoes developed through
biotechnology for enhanced protection against insects (Figure 7). Overall,
there was a modest drop in willingness to buy such products from the highest
levels found between 1995 and early 1999. However, the results for October
2000 and January 2001 showed that consumers were just as willing to consume
insect-protected plants after the StarLink™ incident as before.
As a final question, respondents were asked, “During the past few months
have you done anything or taken any action because of any concerns you may
have about genetically modified foods?” Despite this clear opportunity to
answer “yes,” only 5% of the respondents in the October 2000 and January
2001 surveys said they had done anything. In my October survey, we followed
up and asked that small pool of respondents what they had done. Mainly, they
had sought out more information or had talked to someone. No one reported
boycotting any food company or changing their food-consumption behavior.
Figure 6. Foodstuff avoidance over the previous few months
(Hoban, 2000; IFIC, 2001).
The most common responses involved microbial contami-
nation or pesticides. Only 2 to 3% mentioned anything
related to biotechnology or genetic modification.
CONSUMER VIEWS ON FOOD LABELING
A complex and contentious issue in the United States is whether foods
developed through biotechnology should accordingly carry some type of label.
On this particular subject, how questions are asked clearly has a major impact
on how consumers respond. One neutral way is to simply ask, in an open-
ended question, if they can think of any information not currently included
that they would like to see on food labels. Surveys conducted in October 2000
(Hoban, 2000) and January 2001 (IFIC, 2001) found that only 2% of the people
surveyed responded “genetically modified.” In both cases, three-quarters of
the respondents said they could not think of any additional information they
would like to see on food labels. This is noteworthy in that the interviews took
place after the StarLink™ controversy became a public issue.
Many consumers claim to want information on food labels about how
foods and their ingredients are produced. The Center for Science in the Public
Interest (CSPI) found in May of 2001 that about two-thirds of consumers
wanted foods containing genetically engineered ingredients to be labeled
(see pages 31, 32; CSPI, 2001). However, even more consumers (76%) wanted
labeling for crops grown using pesticides, 65% for crops grown using plant
hormones, and 56% for crops that are imported. In fact, 40% of respondents
said that they would like products containing hybrid corn to be labeled, which
would apply to any food containing oil, high-fructose syrup, or any other
ingredients derived from corn.
Figure 7. American consumers’ willingness to buy potatoes or tomatoes
genetically modified for enhanced resistance to insects
(Hoban, 1996; FMI, 1997; IFIC, 2001).
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One way to measure consumers’ desire for labeling is to determine
willingness to pay for that information. The CSPI survey found that 44% of
consumers would pay “nothing” and another 17% would pay $10 per year on
top of their family’s current annual food bill for such labeling. Only 28% were
willing to pay $50 or more. In fact, of the 17% of consumers who said that
their highest labeling priority was genetic engineering, 50% would pay nothing
or $10 per year for that labeling. Similarly, of the people who believed that
labeling genetically engineered foods should be required, 56% would pay
nothing or $10 per year for it. Although as many as two-thirds of consumers
may desire labeling of GM foods, few appear willing to pay the real costs for
that information, which would result from the need for identity preservation,
testing, certification, etc.
One concern about labeling is that consumers may perceive the information
to be a warning. In fact, when respondents to the CSPI survey were asked
whether foods labeled as containing GM ingredients were just as safe as, not
as safe as, or safer than, similar products without such a label, about 30%
said that the labeled product was less safe. Only 7% said that the GM-labeled
product was safer, and about 33% said that the labeled product was equally safe.
CONCLUSIONS AND IMPLICATIONS
Review of recent research makes it possible to anticipate future consumer
acceptance of agricultural biotechnology in the United States. Given that public
perception of plant biotechnology has not changed much over the past few
years, it is unlikely that acceptance will change much in the future, provided
that no real health problems are encountered with GM foods. Research into
food-shopping preferences and behavior shows that consumers in the United
States tend to be pragmatic in their choices. They select food based upon taste,
value (price), convenience, and nutrition. No one spontaneously reports that
seed genetics influenced their purchasing.
However, animal biotechnology will raise a host of complex issues that will
make it less acceptable than plant biotechnology. Some people view animals as
having feelings and due more respect than plants. Also, animal-rights activists
will step up their protests as new products arrive on the market. Consumer
reaction to transgenic animals, such as those used to produce human organs,
will likely be extreme, particularly if the meat enters the food supply. Faster-
growing fish may meet with poor acceptance, especially if they are labeled
accordingly and/or the opposition groups have a significant impact on media
coverage. Clearly, animal and veterinary scientists should learn from the
experience of plant scientists about the importance of ongoing communication
and social science research. Unfortunately, this may not be the case as
evidenced by their lack of communication on these issues.
Media coverage of agricultural biotechnology over the past few years has
generally been balanced in the United States, at least compared to Europe. It
seems that the media’s focus is shifting to the range of complex issues related to
human genomics, including the controversies of stem-cell research and human
cloning. These issues may generate public concern as the products of medical
biotechnology and genomics come to the market place. In particular, diagnostic
tests and other screening tools will make it possible to identify genetic traits
that predispose humans to disease. This will be controversial if people do not
want to know, particularly where there is no cure for the disease that could be
diagnosed. Also, concerns are already being raised about genetic privacy and
the possibility for genetic discrimination by employers and health-insurance
providers.
Relatively little social-science research has been done to assess public
perceptions of either animal biotechnology or human genomics. Clearly, we
need to start addressing these issues to understand public concerns and hopes,
as well as information needs. In addition, no organizations have stepped
forward to begin the challenging, but vital, job of informing the public about
the future of animal biotechnology and human genetics, as the Council for
Biotechnology Information, NABC, and others have done for plant biotech-
nology. We may look back and realize that the issues associated with plant
biotechnology were easier to address than those with animal or human
applications.
There are many reasons why opinion has remained more positive in America
than in Europe, despite the best attempts of activist groups to promote fear and
uncertainty. American consumers tend to have a greater level of confidence in
scientists and government regulatory agencies, whereas in Europe confidence
has been seriously eroded by mad cow disease and other problems. Scientists
and others have been actively committed to providing the American public
with information for over a decade, whereas EU leaders and scientists have
generally been silent or ineffective. The activists who oppose biotechnology
have relatively little credibility in the United States, partly as a result of terrorist
tactics. In Europe these groups have filled the information vacuum and
established credibility with the public.
America’s relatively young culture tends to focus on the future, whereas
Europeans generally look to the past. Our cultural values include a much
greater appreciation for the role of science and technology in progress and
economic growth. Americans also have feelings about agriculture and food
that differ from those of Europeans. Many Europeans live to eat whereas most
Americans eat to live. European consumers are more concerned with how food
Many Europeans live to eat whereas most
Americans eat to live.
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is produced and by whom, and they have closer connection to farming, due in
part to the fact that they have few public wilderness areas. Their concept of
natural is tied to small-scale farming. This ideology is also present in the United
States among the relatively elite consumers of organic food.
Research and experience have provided some guidelines for providing
relevant information to interested consumers about agricultural biotechnology.
The first thing that people generally want to know is why scientists are using
biotechnology. In other words, what are the benefits? In fact, many American
consumers appreciate the potential of biotechnology for helping people in
developing countries to feed themselves, which is a less persuasive message
for Europeans. American consumers also have a greater appreciation of the
fact that food produced with biotechnology is as safe as, or safer than, food
produced through traditional breeding methods and grown with more chemical
inputs. It is also important to make the point that no technology is without risk
and that those associated with biotechnology are being managed and regulated.
Finally it is worth considering the implications of consumer attitudes toward
biotechnology for land grant university research and extension programs. For
the past year I have been chairing a national task force looking at ways in
which universities can play a more meaningful and credible role in the
discussions and deliberations about biotechnology. In some respects the future
of biotechnology is closely linked to the future of our colleges of agriculture.
Most universities have made major investments in biotechnology research
and now have obligations to openly explain what they are doing and to ensure
they are providing benefits to society in an ethical manner. We also will have
a major role in developing and implementing education programs and fostering
two-way communication. This is appropriate because American consumers
and leaders still trust our universities. We must make sure we maintain that
level of confidence.
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